{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:20:34Z","timestamp":1792513234011,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["23 2892 Pj"],"award-info":[{"award-number":["23 2892 Pj"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014437","name":"Wenner-Gren Foundation","doi-asserted-by":"publisher","award":["WUP2020-0002"],"award-info":[{"award-number":["WUP2020-0002"]}],"id":[{"id":"10.13039\/100014437","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014437","name":"Wenner-Gren Foundation","doi-asserted-by":"publisher","award":["UPD2021-0226"],"award-info":[{"award-number":["UPD2021-0226"]}],"id":[{"id":"10.13039\/100014437","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007232","name":"Radiumhemmets Forskningsfonder","doi-asserted-by":"publisher","award":["231273"],"award-info":[{"award-number":["231273"]}],"id":[{"id":"10.13039\/501100007232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001388","name":"Wenner-Gren Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsradet","doi-asserted-by":"publisher","award":["2020-01902"],"award-info":[{"award-number":["2020-01902"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["4-867\/2023"],"award-info":[{"award-number":["4-867\/2023"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"CIMED","doi-asserted-by":"publisher","award":["2-4384\/2023"],"award-info":[{"award-number":["2-4384\/2023"]}],"id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"CIMED","doi-asserted-by":"publisher","award":["FoUI-963467"],"award-info":[{"award-number":["FoUI-963467"]}],"id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bneo.2025.100172","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:57:37Z","timestamp":1760075857000},"page":"100172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting dysregulated epigenetic and transcription factor networks in KMT2A-rearranged AML using iPSC models"],"prefix":"10.1016","volume":"3","author":[{"given":"Anna","family":"Palau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5226-0372","authenticated-orcid":false,"given":"Jonas","family":"Thier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6990-9218","authenticated-orcid":false,"given":"Aonghus","family":"Naughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Tae-Jun Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cabrerizo Granados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6625-8348","authenticated-orcid":false,"given":"Sophia","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6554-5608","authenticated-orcid":false,"given":"Bogumi\u0142","family":"Kaczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1872-1186","authenticated-orcid":false,"given":"Xiangfu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Arner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2335-3370","authenticated-orcid":false,"given":"Vanessa","family":"Lundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3272-2505","authenticated-orcid":false,"given":"Andreas","family":"Lennartsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.bneo.2025.100172_bib1","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.3390\/ijms25169023","article-title":"KMT2A rearrangements in leukemias: molecular aspects and therapeutic perspectives","volume":"25","author":"Guarnera","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.bneo.2025.100172_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.exphem.2015.05.009","article-title":"Epigenetic aberrations in acute myeloid leukemia: early key events during leukemogenesis","volume":"43","author":"Eriksson","year":"2015","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bneo.2025.100172_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ctrv.2017.06.006","article-title":"Therapeutic applications of histone deacetylase inhibitors in sarcoma","volume":"59","author":"Tang","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"13","key":"10.1016\/j.bneo.2025.100172_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174794","article-title":"BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline glioma","volume":"134","author":"Watanabe","year":"2024","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.bneo.2025.100172_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2016.11.018","article-title":"Human AML-iPSCs reacquire leukemic properties article human AML-iPSCs reacquire leukemic properties after differentiation and model clonal variation of disease","volume":"20","author":"Chao","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.bneo.2025.100172_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2017.01.009","article-title":"Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia","volume":"20","author":"Kotini","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.bneo.2025.100172_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2021.01.011","article-title":"Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bneo.2025.100172_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-025-02740-1","article-title":"SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms","author":"Thier","year":"2025","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.bneo.2025.100172_bib8","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1182\/bloodadvances.2020002517","article-title":"Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML","volume":"5","author":"Mareschal","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.bneo.2025.100172_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2019.03.085","article-title":"Induction of human pluripotent stem cell-derived natural killer cells for immunotherapy under chemically defined conditions","volume":"515","author":"Matsubara","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bneo.2025.100172_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2105-15-144","article-title":"MOIRAI: a compact workflow system for CAGE analysis","volume":"15","author":"Hasegawa","year":"2014","journal-title":"BMC Bioinformatics"},{"issue":"7493","key":"10.1016\/j.bneo.2025.100172_bib11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nature13182","article-title":"A promoter-level mammalian expression atlas","volume":"507","author":"Forrest","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bneo.2025.100172_bib12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/ng.375","article-title":"The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line","volume":"41","author":"FANTOM Consortium","year":"2009","journal-title":"Nat Genet"},{"issue":"26","key":"10.1016\/j.bneo.2025.100172_bib13","doi-asserted-by":"crossref","first-page":"15776","DOI":"10.1073\/pnas.2136655100","article-title":"Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage","volume":"100","author":"Shiraki","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"10.1016\/j.bneo.2025.100172_bib14","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1038\/onc.2016.488","article-title":"MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia","volume":"36","author":"Prange","year":"2017","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.bneo.2025.100172_bib15","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/s41588-021-00941-9","article-title":"Automated CUT&Tag profiling of chromatin heterogeneity in mixed-lineage leukemia","volume":"53","author":"Janssens","year":"2021","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.bneo.2025.100172_bib16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/MCB.24.2.617-628.2004","article-title":"Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization","volume":"24","author":"Zeisig","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.bneo.2025.100172_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng765","article-title":"MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia","volume":"30","author":"Armstrong","year":"2002","journal-title":"Nat Genet"},{"issue":"1-2","key":"10.1016\/j.bneo.2025.100172_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cell.2012.11.047","article-title":"Sequence-specific transcription factor NF-Y displays histone-like DNA binding and H2B-like ubiquitination","volume":"152","author":"Nardini","year":"2013","journal-title":"Cell"},{"issue":"7414","key":"10.1016\/j.bneo.2025.100172_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Dunham","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bneo.2025.100172_bib20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2147\/OTT.S236854","article-title":"GAS2 promotes cell proliferation and invasion and suppresses apoptosis in pediatric T-cell acute lymphoblastic leukemia and activates wnt\/\u03b2-catenin pathway","volume":"13","author":"Kong","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"8","key":"10.1016\/j.bneo.2025.100172_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0329622","article-title":"Mechanism of Astragaloside-Brucea javanica oil nanoemulsion against oral squamous cell carcinoma through CDK1\/MTFR2: network pharmacology, bioinformatics, and experimental studies","volume":"20","author":"Lai","year":"2025","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bneo.2025.100172_bib22","first-page":"131","article-title":"The genetics of the E2F family of transcription factors: shared functions and unique roles","volume":"1602","author":"DeGregori","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.bneo.2025.100172_bib23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s12032-025-02973-1","article-title":"From cell cycle control to cancer therapy: exploring the role of CDK1 and CDK2 in tumorigenesis","volume":"42","author":"Gupta","year":"2025","journal-title":"Med Oncol"},{"issue":"8","key":"10.1016\/j.bneo.2025.100172_bib24","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/ng.405","article-title":"Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II","volume":"41","author":"Schwarz","year":"2009","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.bneo.2025.100172_bib25","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1007\/s00018-020-03702-9","article-title":"BCL2L13: physiological and pathological meanings","volume":"78","author":"Meng","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.bneo.2025.100172_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ncb894","article-title":"Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis","volume":"5","author":"Shirane","year":"2003","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/j.bneo.2025.100172_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12859-022-05084-0","article-title":"xcore: an R package for inference of gene expression regulators","volume":"24","author":"Migda\u0142","year":"2023","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"10.1016\/j.bneo.2025.100172_bib28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood-2014-06-581082","article-title":"Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia","volume":"125","author":"Xu","year":"2015","journal-title":"Blood"},{"issue":"7151","key":"10.1016\/j.bneo.2025.100172_bib29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature05944","article-title":"In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state","volume":"448","author":"Wernig","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bneo.2025.100172_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.stem.2007.05.014","article-title":"Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution","volume":"1","author":"Maherali","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bneo.2025.100172_bib31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-1-59745-418-6_16","article-title":"In vitro differentiation of mouse embryonic stem cells as a model of early hematopoietic development","volume":"538","author":"Sroczynska","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"5","key":"10.1016\/j.bneo.2025.100172_bib32","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.devcel.2016.01.024","article-title":"Dynamic gene regulatory networks drive hematopoietic specification and differentiation","volume":"36","author":"Goode","year":"2016","journal-title":"Dev Cell"},{"issue":"3","key":"10.1016\/j.bneo.2025.100172_bib33","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cell.2016.02.062","article-title":"Transcriptional regulators compete with nucleosomes post-replication","volume":"165","author":"Ramachandran","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bneo.2025.100172_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41588-018-0270-1","article-title":"Subtype-specific regulatory network rewiring in acute myeloid leukemia","volume":"51","author":"Assi","year":"2019","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.bneo.2025.100172_bib35","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1158\/2159-8290.CD-16-0237","article-title":"Targeting chromatin regulators inhibits leukemogenic gene expression in NPM1 mutant leukemia","volume":"6","author":"K\u00fchn","year":"2016","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.bneo.2025.100172_bib36","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/leu.2011.277","article-title":"Downregulation of MEIS1 impairs long-term expansion of CD34 + NPM1-mutated acute myeloid leukemia cells","volume":"26","author":"Woolthuis","year":"2012","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.bneo.2025.100172_bib37","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1182\/blood-2011-06-359406","article-title":"NF-Y is necessary for hematopoietic stem cell proliferation and survival","volume":"119","author":"Bungartz","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bneo.2025.100172_bib38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1158\/2159-8290.CD-22-0416","article-title":"A molecular switch between mammalian MLL complexes dictates response to menin\u2013MLL inhibition","volume":"13","author":"Soto-Feliciano","year":"2023","journal-title":"Cancer Discov"},{"issue":"20","key":"10.1016\/j.bneo.2025.100172_bib39","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1101\/gad.13.20.2691","article-title":"Functional antagonism of the polycomb-group genes eed and Bmi1 in hemopoietic cell proliferation","volume":"13","author":"Lessard","year":"1999","journal-title":"Genes Dev"},{"issue":"70","key":"10.1016\/j.bneo.2025.100172_bib40","doi-asserted-by":"crossref","first-page":"115002","DOI":"10.18632\/oncotarget.22839","article-title":"Polycomb protein RING1A limits hematopoietic differentiation in myelodysplastic syndromes","volume":"8","author":"Palau","year":"2017","journal-title":"Oncotarget"},{"issue":"49","key":"10.1016\/j.bneo.2025.100172_bib41","doi-asserted-by":"crossref","first-page":"20980","DOI":"10.1073\/pnas.1012525107","article-title":"Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas","volume":"107","author":"Sneeringer","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.bneo.2025.100172_bib42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41556-022-00850-x","article-title":"EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis","volume":"24","author":"Wang","year":"2022","journal-title":"Nat Cell Biol"},{"issue":"13","key":"10.1016\/j.bneo.2025.100172_bib43","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1073\/pnas.1202258109","article-title":"Polycomb repressive complex 2 is required for MLL-AF9 leukemia","volume":"109","author":"Neff","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.bneo.2025.100172_bib44","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccr.2011.09.008","article-title":"CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis","volume":"20","author":"Tan","year":"2011","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.bneo.2025.100172_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","article-title":"A bivalent chromatin structure marks key developmental genes in embryonic stem cells","volume":"125","author":"Bernstein","year":"2006","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bneo.2025.100172_bib46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tig.2019.11.004","article-title":"The bivalent genome: characterization, structure, and regulation","volume":"36","author":"Blanco","year":"2020","journal-title":"Trends Genet"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328025001074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328025001074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:25:13Z","timestamp":1773897913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328025001074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2950328025001074"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2025.100172","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting dysregulated epigenetic and transcription factor networks in KMT2A-rearranged AML using iPSC models","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2025.100172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100172"}}